Similar gender-specific differences in symptom severity have also been observed in other neuromuscular diseases, such as SCN4A mutation-associated hypokalemic periodic paralysis, suggesting a potential area for further investigation of CMT2Z (Li et al., 2012). The gene discussed is SCN4A; the disease is neuromuscular disease.